isoproterenol has been researched along with atosiban in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruckmaier, RM; Inderwies, T; Kiossis, E; Riedl, J | 1 |
| Advenier, C; Bardou, M; Breuiller-Fouché, M; Cecchi, R; Croci, T; Descamps, L; Fradin, Y; Germain, G; Guagnini, F; Leroy, MJ; Marini, P; Pascal, M; Rouget, C; Viviani, N | 1 |
| Devost, D; Goupil, E; Hébert, TE; Iorio-Morin, C; Laporte, SA; Pétrin, D; Wrzal, PK; Zingg, HH | 1 |
3 other study(ies) available for isoproterenol and atosiban
| Article | Year |
|---|---|
Effects of alpha- and beta-adrenergic receptor stimulation and oxytocin receptor blockade on milking characteristics in dairy cows before and after removal of the teat sphincter.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Cattle; Female; Hormone Antagonists; Isoproterenol; Kinetics; Lactation; Mammary Glands, Animal; Milk; Milk Ejection; Phenylephrine; Pressure; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Oxytocin; Vasotocin | 2003 |
In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agoni
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Benzoates; Binding, Competitive; Cell Line; Cell Line, Tumor; Cells, Cultured; Cyclic AMP; Female; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoproterenol; Macaca fascicularis; Molecular Structure; Myometrium; Obstetric Labor, Premature; Oxytocin; Pregnancy; Propanolamines; Receptors, Adrenergic, beta-3; Sulfonamides; Tocolytic Agents; Transfection; Uterine Contraction; Vasotocin | 2007 |
Allosteric interactions between the oxytocin receptor and the β2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Allosteric Regulation; Atenolol; Cell Line; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Female; Humans; Immunoprecipitation; Isoproterenol; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myometrium; Oxytocin; Phosphorylation; Propranolol; Protein Binding; Protein Multimerization; Receptors, Adrenergic, beta-2; Receptors, Oxytocin; Recombinant Fusion Proteins; Signal Transduction; Timolol; Vasotocin | 2012 |